Thermo Fisher Scientific (Finance I) B.V. | - | 4.38% | - | - | 2,072,000 |
JPMorgan Chase & Co. | - | 4.14% | - | - | 1,817,000 |
Bayer AG | - | 3.96% | - | - | 1,574,000 |
UBS Group AG | - | 3.86% | - | - | 1,464,000 |
American Medical Systems Europe B.V. | - | 3.59% | - | - | 1,500,000 |
CDP Financial Inc. | - | 3.28% | - | - | 1,423,000 |
DSV Finance B.V | - | 3.22% | - | - | 1,355,000 |
Novo Nordisk Finance (Netherlands) B.V. | - | 3.20% | - | - | 1,355,000 |
Morgan Stanley | - | 3.09% | - | - | 1,285,000 |
Alphabet Inc. | - | 3.03% | - | - | 1,290,000 |
VanEck ETFs N.V. - VanEck iBoxx EUR Corporates UCITS ETF is an exchange traded fund launched and managed by Think Capital Asset Management B.V. The fund invests in the fixed income markets of Europe. It primarily invests Euro denominated, investment grade bonds issued by corporate and all non-government issuers which are rated investment grade by S&P, Moody’s and Fitch and have a minimum maturity of 1.5 years. The fund seeks to replicate the performance of the Markit iBoxx EUR Liquid Corporates Index, by investing in securities as per their weightings in the Index. VanEck ETFs N.V. - VanEck iBoxx EUR Corporates UCITS ETF was formed on April 14, 2011 and is domiciled in Netherlands.